Published in Klin Padiatr on January 01, 1979
An unusual cause of macular infarction: protein-losing enteropathy. Int Ophthalmol (2012) 0.75
Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum (1995) 2.48
Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr (1996) 1.80
Laboratory testing for thrombophilia in pediatric patients. On behalf of the Subcommittee for Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis (ISTH). Thromb Haemost (2002) 1.56
Endomysium antibodies in coeliac disease: an improved method. Gut (1994) 1.54
Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children. Br Heart J (1993) 1.43
Relationship between thrombin generation and carotid intima-media thickness. Hamostaseologie (2010) 1.40
Trace element transfer from the mother to the newborn--investigations on triplets of colostrum, maternal and umbilical cord sera. Eur J Clin Nutr (1999) 1.37
A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity. Blood (1982) 1.12
Changes in the concentrations of trace elements in human milk during lactation. J Trace Elem Med Biol (1998) 1.09
Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost (2002) 1.05
Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia. Pediatrics (1995) 1.01
Longer aPTT values in healthy children than in adults: no single cause. Thromb Res (1997) 0.97
Lupus anticoagulant and factor XII activity in children with prolonged PTT. Thromb Res (1996) 0.97
Concentrations of trace elements in sera of newborns, young infants, and adults. Biol Trace Elem Res (1999) 0.96
Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost (2003) 0.96
[Incidence of coeliac disease in children in Austria (author's transl)]. Z Kinderheilkd (1975) 0.93
Precipitins to aqueous extracts of flour in coeliac disease. Lancet (1970) 0.91
Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thromb Haemost (1998) 0.90
The role of inherited thrombotic disorders in the etiology of Legg-Calvé-Perthes disease. J Pediatr Orthop (1999) 0.90
Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma. J Thromb Haemost (2003) 0.88
Concentrations of selected trace elements in human milk and in infant formulas determined by magnetic sector field inductively coupled plasma-mass spectrometry. Biol Trace Elem Res (2000) 0.87
Influence of high molecular weight factor VIII on the measurement of low molecular weight factor VIII procoagulant in different assay systems. Br J Haematol (1982) 0.87
Severe bleeding due to factor V inhibitor after repeated operations using fibrin sealant containing bovine thrombin. Thromb Haemost (1997) 0.86
Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood (1988) 0.85
Maternal selenium status in Slovenia and its impact on the selenium concentration of umbilical cord serum and colostrum. Eur J Clin Nutr (2000) 0.84
Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBA. Blood Coagul Fibrinolysis (2002) 0.84
Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation, and fibrinogen levels. Atherosclerosis (2010) 0.84
Persistent cell mediated immune-deficiency following infantile stress during the first 6 months of life. Eur J Pediatr (1976) 0.83
Thrombin generation in severely obese children. J Thromb Haemost (2006) 0.83
Heparin inhibition of the cytostatic effect of Adriamycin on cultured lymphocytes. Acta Haematol (1981) 0.82
Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II. Acta Paediatr (2001) 0.82
Haemostatic changes in tall girls treated with high doses of ethinyloestradiol. Eur J Pediatr (1980) 0.81
Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries. Haemophilia (2000) 0.81
Thrombin generation in factor VIII-depleted neonatal plasma: nearly normal because of physiologically low antithrombin and tissue factor pathway inhibitor. J Thromb Haemost (2006) 0.81
Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obes Relat Metab Disord (2000) 0.81
Flow cytometric detection of intracellular platelet antigens. Cytometry (1996) 0.81
Effects of short-term energy restriction and physical training on haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obes Relat Metab Disord (2001) 0.80
Plasma concentrations after intravenous administration of phylloquinone (vitamin K(1)) in preterm and sick neonates. Thromb Res (2000) 0.80
Malignant stroke in an adolescent with a homozygous MTHFR 677CT mutation and intake of hormonal contraceptives. Hamostaseologie (2009) 0.80
Hyporeactivity of neonatal platelets is not caused by preactivation during birth. Eur J Pediatr (1997) 0.80
Effect of heparin, platelets, activated platelets, platelet fragments, and hematocrit on activated clotting time. Artif Organs (2000) 0.79
Shorter PFA-100 closure times in neonates than in adults: role of red cells, white cells, platelets and von Willebrand factor. Acta Paediatr (2001) 0.79
Activation of the haemostatic system in children with juvenile rheumatoid arthritis correlates with disease activity. Thromb Res (1998) 0.79
[Pericardial effusion in celiac disease--an incidental finding?]. Wien Klin Wochenschr (2000) 0.79
[Value of ultrasound in diagnosis of celiac disease]. Ultraschall Med (1996) 0.79
Recombinant factor VIIa does not induce hypercoagulability in vitro. Thromb Haemost (1999) 0.78
More on: mild hemophilia A and inhibitor development. J Thromb Haemost (2004) 0.78
Sonographic findings in celiac disease. J Pediatr Gastroenterol Nutr (1993) 0.78
Expression of aromatase P450(AROM) in the human fetal and early postnatal cerebral cortex. Brain Res (2012) 0.78
Normalization of haemostatic alterations in overweight children with weight loss due to lifestyle intervention. Atherosclerosis (2011) 0.78
Concentrations of trace elements in extensively hydrolysed infant formulae and their estimated daily intakes. Ann Nutr Metab (2000) 0.78
Screening for haemorrhagic disorders in paediatric patients by means of a questionnaire. Hamostaseologie (2009) 0.78
Method for the determination of vitamin K1(20) in human plasma by stable isotope dilution/gas chromatography/mass spectrometry. J Mass Spectrom (1996) 0.78
[Familial asphyctic thorax dystrophy (Jeune's disease)]. Arch Kinderheilkd (1969) 0.78
Regular smoking is not associated with increased thrombin generation in young adults. J Thromb Haemost (2013) 0.77
Activation of the clotting system: heparin-coated versus non coated systems for extracorporeal circulation. Int J Artif Organs (1997) 0.77
No differences in support of thrombin generation by neonatal or adult platelets. Hamostaseologie (2009) 0.77
Diagnostic and therapeutic considerations on inherited platelet disorders in neonates and children. Klin Padiatr (2010) 0.77
Simple decomposition procedure for determination of selenium in whole blood, serum and urine by hydride generation atomic absorption spectroscopy. J Trace Elem Electrolytes Health Dis (1993) 0.77
Trace elements in formulas based on cow and soy milk and in Austrian cow milk determined by inductively coupled plasma mass spectrometry. Biol Trace Elem Res (1998) 0.77
Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin. Platelets (2010) 0.77
High titre inhibitor after continuous factor VIII administration for surgery in a young infant. Haemophilia (2000) 0.77
Giant platelets in erucic acid therapy for adrenoleukodystrophy. Lancet (1993) 0.76
The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents. J Pediatr Endocrinol Metab (2001) 0.76
Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Metabolism (2000) 0.76
A novel type of mutation at the propeptide cleavage site (AlA+1Thr) causing symptomatic protein C type II deficiency. Thromb Res (2000) 0.76
[Fetal alcohol syndrome and malignant tumors]. Wien Klin Wochenschr (1982) 0.76
Comparative evaluation of PAR1, GPIb-IX-V, and integrin αIIbβ3 levels in cord and adult platelets. Hamostaseologie (2010) 0.76
Portal vein thrombosis in a 17-year-old female adolescent with essential thrombocytosis. Pediatr Hematol Oncol (1997) 0.76
Demonstration of Epstein-Barr virus DNA in a previously healthy boy with fulminant hepatic failure. Eur J Pediatr (1986) 0.76
In vivo thrombin generation in neonates. J Thromb Haemost (2004) 0.75
Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents. Blood Coagul Fibrinolysis (2000) 0.75
Down's syndrome and celiac disease. J Pediatr Gastroenterol Nutr (1990) 0.75
Calibrated automated thrombin generation in paediatric patients with inflammatory bowel disease. Hamostaseologie (2009) 0.75
Cutaneous necrosis associated with acquired severe protein S deficiency. Thromb Haemost (1994) 0.75
Antiphospholipid antibodies in children. Thromb Res (2001) 0.75
Enhanced thrombin generation in plasma of severe thrombocytopenic patients due to rFVIIa. Hamostaseologie (2008) 0.75
New therapies for severe meningococcal disease. Lancet (1998) 0.75
Treatment of fulminant meningococcemia with recombinant tissue plasminogen activator. Thromb Haemost (1995) 0.75
Alpha-2-macroglobulin inhibits the anticoagulant action of activated protein C in cord and adult plasma. Haemostasis (2001) 0.75
Thrombin generation in paediatric patients with congenital heart disease. Determination by calibrated automated thrombography. Hamostaseologie (2008) 0.75
Inherited resistance to activated protein C in a boy with multiple thromboses in early infancy. Eur J Pediatr (1995) 0.75
[You make the diagnosis. Heterozygote factor XI deficiency]. Padiatr Padol (1991) 0.75
Effects of antithrombin and protein C on thrombin generation in newborn and adult plasma. Thromb Res (1999) 0.75
[Anti Ko(a) as a cause of neonatal alloimmune thrombocytopenia]. Beitr Infusionsther Transfusionsmed (1994) 0.75
Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitro. Blood Coagul Fibrinolysis (2000) 0.75
Inverse correlation between thyroid function and hemostatic markers for coronary heart disease in obese children and adolescents. J Pediatr Endocrinol Metab (2001) 0.75
Arthralgia and digital clubbing in a child: hypertrophic osteoarthropathy with inflammatory pseudotumour of the lung. Scand J Rheumatol (2004) 0.75
Anticoagulation for continuous arteriovenous hemofiltration in children. Blood Purif (1988) 0.75
Prothrombin fragment 1+2 during oral anticoagulation in congenital nephrotic syndrome. Pediatr Nephrol (1998) 0.75
[Relevance of a single dose of 270 microg/kg recombinant factor VIIa for the treatment of patients with haemophilia and inhibitors - Recommendations from the GTH experts]. Hamostaseologie (2009) 0.75
Effects of alpha(2)-macroglobulin and antithrombin on thrombin generation and inhibition in cord and adult plasma. Thromb Res (2001) 0.75
[Austrian haemophilia registry: up-date 2008 ]. Hamostaseologie (2009) 0.75
[Pernio as cause of a blue toe syndrome]. Klin Padiatr (2006) 0.75
[Is the DDAVP-test helpful to diagnose children?]. Hamostaseologie (2010) 0.75
Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma. Thromb Haemost (1995) 0.75
Thrombin-Hirudin complex formation, thrombin-antithrombin III complex formation, and thrombin generation after intrinsic activation of plasma. Thromb Haemost (1994) 0.75
Gly-pro-arg-pro (GPRP) enhances free thrombin. Thromb Res (1995) 0.75
[Hepatitis C antibodies in children and adolescents with congenital blood coagulation disorders]. Wien Klin Wochenschr (1991) 0.75
[You make the diagnosis. Heterozygote factor V deficiency. Venous ectasias in the area of the Kiesselbach locus]. Padiatr Padol (1988) 0.75